Search

everythinglearnresearchcommunity

for

Search:↓

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

No cure for female pattern hair loss, but various effective treatments exist.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Melatonin may reduce skin damage caused by X-rays in rats.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.